Skip to main content

Table 1 Reasons for exclusion in 937 out of 2505 men screened

From: Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN41194621]

Reason n %
LEAD not confirmed 277 11.1
Patient unwilling 248 9.9
Lipid-modifying agent 87 3.5
Blood test results* 64 2.6
Renal or hepatic disease 45 1.8
Other significant disease 36 1.4
Unstable angina 17 0.7
Died before trial entry 15 0.6
Malignant disease 16 0.6
Other, unknown 132 5.3
Total 937 37.4
  1. *At screening (eg raised creatinine).